Table 1.
Demographic or Clinical Characteristic | Chemotherapy Plus Cetuximab (n = 106) |
Chemotherapy Followed by Cetuximab (n = 118) |
||
---|---|---|---|---|
No. of Patients | % | No. of Patients | % | |
Age | ||||
Median | 65 | 63 | ||
Minimum | 35 | 34 | ||
Maximum | 82 | 82 | ||
Sex | ||||
Male | 61 | 58 | 64 | 54 |
Female | 45 | 42 | 54 | 46 |
Hispanic | ||||
Yes | 2 | 2 | 6 | 5 |
No | 97 | 92 | 105 | 89 |
Unknown | 7 | 7 | 7 | 6 |
Race | ||||
White | 93 | 88 | 94 | 80 |
Black | 9 | 8 | 11 | 9 |
Asian | 4 | 4 | 10 | 8 |
Unknown | 0 | 0 | 3 | 3 |
Cell type | ||||
Adenocarcinoma | 59 | 56 | 69 | 58 |
Squamous | 17 | 16 | 22 | 19 |
Large cell | 6 | 6 | 6 | 5 |
BAC | 1 | 1 | 2 | 2 |
Other non–small cell | 23 | 22 | 19 | 16 |
Missing | 0 | 0 | 0 | 0 |
Performance status | ||||
0 | 43 | 41 | 52 | 44 |
1 | 63 | 59 | 66 | 56 |
Stage | ||||
IIIB | 11 | 10 | 10 | 8 |
IV | 95 | 90 | 108 | 92 |
Abbreviation: BAC, bronchioloalveolar cell.